Gland Pharma will be investing over ₹400 crore in adding up capabilities to their existing facility in the Genome Valley he to manufacture biologicals, biosimilar, antibodies and recombinant Insulin. The company will recrureit... Full Story
Bristol Myers Squibb to invest Rs. 800 cr for drug development in Hyderabad.
Bristol Myers Squibb, a world's leading biopharmaceutical company will establish a state of-the-art site here to expand its global drug... Full Story
Cadila Pharmaceuticals to invest ₹100 crore to set up formulations facility in Odisha.
Ahmedabad-based Cadila Pharmaceuticals will invest ₹100 crore to set up a pharmaceuticals formulations manufacturing facility at Malipada near Bhubaneswar in... Full Story